Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
10/2002
10/16/2002CN1092652C 2-imidazolinylaminoindole compound and composition containing the same use
10/16/2002CN1092643C Certain aminomethyl phenylidazole derivatives, for intensifying memory
10/15/2002US6465503 Selective urokinase inhibitors
10/15/2002US6465500 Indole derivatives as 5-HT1 agonists
10/15/2002US6465484 Tyrosine kinase inhibitors; cancer, atherosclerosis, diabetic retinopathy, autoimmune diseases, inflammatory diseases
10/15/2002US6465482 Arylpiperazinyl-cyclohexyl indole derivatives for the treatment of depression
10/15/2002US6465467 Diseases related to the 5-ht2c receptor, especially eating, memory, mood, urinary and anxiety disorders, schizophrenia, pain, sexual dysfunctions
10/15/2002US6465464 Method of using (2-imidazolin-2-ylamino) quinoxalines in treating ocular neural injury
10/15/2002US6465449 Heteroaromatic bicyclic derivatives useful as anticancer agents
10/15/2002CA2256438C Aromatic amidine derivatives useful as selective thrombin inhibitors
10/15/2002CA2066943C Heterocyclically substituted phenylacetic acid derivatives, processes for their preparation and their use in medicaments
10/10/2002WO2002080161A2 Optical data carrier that contains a merocyanine dye as the light-absorbing compound in the information layer
10/10/2002WO2002080159A1 Optical data carrier that contains a cyanine dye as the light-absorbing compound in the information layer
10/10/2002WO2002079198A1 Pyridazinone aldose reductase inhibitors
10/10/2002WO2002079197A1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
10/10/2002WO2002079194A1 Ccr5 antagonists useful for treating aids
10/10/2002WO2002079193A1 Inhibitors of cyclin dependent kinases as anti-cancer agent
10/10/2002WO2002079192A1 Novel tyrosine kinase inhibitors
10/10/2002WO2002079188A1 Pyrrolidine sulfonamides
10/10/2002WO2002079187A1 Methoxy-1,3,5-triazine derivatives as antiviral agents
10/10/2002WO2002079173A1 Benzotriazoles and their use as uv light stabilisers
10/10/2002WO2002079169A1 Cyano-substituted dihydropyrimidine compounds and their use to treat diseases
10/10/2002WO2002079168A1 Imidazolyl derivatives useful as histamine h3 receptor ligands
10/10/2002WO2002079154A1 Substituted carbazoles as inhibitors of spla2
10/10/2002WO2002079152A1 Cyclopropylindole derivatives as selective serotonin reuptake inhibitors
10/10/2002WO2002079149A2 Novel cyano-substituted dihydropyrimidine compounds and their use to treat diseases
10/10/2002WO2002079147A2 Inhibitors of prenyl-protein transferase
10/10/2002WO2002079146A2 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
10/10/2002WO2002079145A1 BENZAMIDE INHIBITORS OF FACTOR Xa
10/10/2002WO2002078702A1 Inhibitors of prenyl-protein transferase
10/10/2002WO2002078693A2 N-(2-arylethyl)benzylamines as antagonists of the 5-ht6 receptor
10/10/2002WO2002078659A1 Dyeing composition for dyeing keratinous fibres comprising a cationic azo-dye
10/10/2002WO2002078657A1 Dyeing composition for dyeing keratinous fibres comprising a cationic azo-dye
10/10/2002WO2002078641A2 Pyrrolidine sulfonamides
10/10/2002WO2002078639A2 A method of treating proliferative diseases using eg5 inhibitors
10/10/2002WO2002078626A2 Therapeutic combinations for cardiovascular and inflammatory indications
10/10/2002WO2002078625A2 Therapeutic combinations for cardiovascular and inflammatory indications
10/10/2002WO2002066440A8 Diaminopyrazole derivatives and their use for oxidation dyeing of keratinous fibres
10/10/2002WO2002044173A3 Herbicidal heterocycles
10/10/2002WO2002043667A3 HYDROLYSIS OF [R(R*,R*)]-2-(4-FLUOROPHENYL)-β,δ -DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4-[(PHENYLAMINO)CARBONYL]-1H-PYRROLE-1-HEPTANOIC ACID ESTERS WITH CALCIUM HYDROXIDE
10/10/2002WO2001072728A9 Novel piperazine derivatives
10/10/2002US20020147343 Cell antiproliferative agents; anticancer agents
10/10/2002US20020147339 5-cyano-2-aminopyrimidine derivatives
10/10/2002US20020147229 Pharmaceuticals
10/10/2002US20020147214 Enzyme inhibitors; anticancer agents
10/10/2002US20020147194 Psychological disorders; antiserotonin agents; headache therapy
10/10/2002US20020147188 Protease inhibitors
10/10/2002US20020147181 Viricides
10/10/2002DE10117204A1 In 6-Stellung substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel In the 6-position substituted indolinones, their preparation and their use as medicaments
10/10/2002DE10114775A1 2-Mercapto-4,5-diarylimidazolderivate und ihre Verwendung in der Pharmazie 2-mercapto-4,5-diarylimidazolderivate and their use in the pharmaceutical
10/10/2002CA2442525A1 Cyclopropylindole derivatives as selective serotonin reuptake inhibitors
10/10/2002CA2442484A1 Cyano-substituted dihydropyrimidine compounds and their use to treat diseases
10/10/2002CA2442482A1 Novel cyano-substituted dihydropyrimidine compounds and their use to treat diseases
10/10/2002CA2442476A1 Pyridazinone aldose reductase inhibitors
10/10/2002CA2442455A1 A method of treating proliferative diseases using eg5 inhibitors
10/10/2002CA2442428A1 Novel tyrosine kinase inhibitors
10/10/2002CA2442328A1 Therapeutic combinations for cardiovascular and inflammatory indications
10/10/2002CA2441077A1 Substituted carbazoles as inhibitors of spla2
10/10/2002CA2440228A1 Inhibitors of cyclin dependent kinases as anti-cancer agent
10/10/2002CA2438272A1 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
10/09/2002WO2001079168A1 Nitrogenous compounds and antiviral drugs containing the same
10/09/2002EP1247810A1 Novel benzotriazoles anti-inflammatory compounds
10/09/2002EP1247809A2 Triazine compounds useful as sorbitol dehydrogenase inhibitors
10/09/2002EP1247804A1 Pyrimidine-thioalkyl and alkylether compounds
10/09/2002EP1247803A2 Indolinone compounds suitable for modulation of protein kinases
10/09/2002EP1246823A1 Pyrimidine and triazine kinase inhibitors
10/09/2002EP1246819A1 A method for the preparation of substituted benzene derivatives
10/09/2002EP1246817A1 4-phenyl-1-piperazinyl, -piperidinyl and -tetrahydropyridyl derivatives
10/09/2002EP1246815A1 Phenylpiperazinyl derivatives
10/09/2002EP1246808A1 1,2-diaryl benzimidazoles for treating illnesses associated with a microglia activation
10/09/2002EP1246807A2 Novel hydantoin, thiohydantoin, pyrimidinedione and thioxopyrimidinone derivatives, preparation method and use as medicines
10/09/2002EP1246619A1 Urotensin-ii receptor antagonists
10/09/2002EP0853477B1 At1-receptor antagonists for preventing and treating postischemic renal failure and for protecting ischemic kidneys
10/09/2002EP0830342B1 Azolyl oxybenzyl alkoxyacrylic acid esters, process for producing them and their use
10/09/2002EP0810996B1 Imidazolidinone derivatives as corrosion inhibitors
10/09/2002CN1373662A 3(5)-amino-pyrazole derivs., process for their preparation and their use as antitumor agents
10/09/2002CN1092193C Prolylendopeptidase inhibitors
10/09/2002CN1092192C Pyrrolyl tetrahydroquinoxalin diones, their production and use in treatment of diseases
10/09/2002CA2405690A1 Nitrogen-containing compounds and antiviral drugs containing the same
10/08/2002US6462194 2,4-disubstituted pyrrolidine-3-carboxylic acid derivatives
10/08/2002US6462069 Kinase inhibitors; anticancer agents
10/08/2002US6462068 Heterocyclylmethyl-substituted pyrazole derivatives
10/08/2002US6462048 3-(2-(4-methylpiperazin-1-yl)-benzylidene)-1,3-dihydro-indol-2-one for example; useful as psychotherapeutic agents
10/08/2002US6462044 Therapy for sexual disorders
10/08/2002US6462036 Inhibiting signal transduction by modulating activity of receptor and nonreceptor tyrosine and serine/threonine kinases to regulate and modulate abnormal or inappropriate cell proliferation, differentiation, or metabolism
10/08/2002CA2196769C Benzimidazole derivatives having dopaminergic activity
10/08/2002CA2145775C 1,4-disubstituted piperazines useful in the therapy of the asthma and of the inflammation of the respiratory tract
10/08/2002CA2095361C Optical isomers of 7-¬3-(1,1-dialkylmethyl-1-amino)-1-pyrrolidinyl|-quinolones and naphthyridones as antibacterial agents
10/08/2002CA2066083C Benzodiazepine analogs as cholecystokinin antagonists
10/06/2002WO2003088897A2 Fab i inhibitors
10/06/2002CA2444597A1 Fab i inhibitors
10/03/2002WO2002077048A2 Ion-sensitive cationic polymers and fibrous items using same
10/03/2002WO2002076979A1 1,2,3,4-tetrahydroisoquinolines derivatives as urotensin ii receptor antagonists
10/03/2002WO2002076978A1 Δ1 pyrrolines
10/03/2002WO2002076977A2 Rho-kinase inhibitors
10/03/2002WO2002076976A2 Rho-kinase inhibitors
10/03/2002WO2002076957A1 Activator for peroxisome proliferator-activated receptor
10/03/2002WO2002076953A1 New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors
10/03/2002WO2002076952A1 Methods of synthesizing heteroatom-bearing ligands and intermediate used therefor
10/03/2002WO2002076951A1 2-mercapto-4,5-diarylimidazole derivatives and the use thereof as cyclooxygenase inhibitors
1 ... 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 ... 626